Canada markets closed

Syndax Pharmaceuticals, Inc. (SNDX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
16.01+0.87 (+5.75%)
At close: 4:00PM EDT
Currency in USD

Valuation Measures

Market Cap (intraday) 5617.17M
Enterprise Value 3448.01M
Trailing P/E N/A
Forward P/E 1-8.38
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)406.84
Price/Book (mrq)4.18
Enterprise Value/Revenue 3295.33
Enterprise Value/EBITDA 6-7.60

Trading Information

Stock Price History

Beta (5Y Monthly) 1.78
52-Week Change 3138.60%
S&P500 52-Week Change 314.01%
52 Week High 321.97
52 Week Low 35.35
50-Day Moving Average 315.86
200-Day Moving Average 315.57

Share Statistics

Avg Vol (3 month) 3354.61k
Avg Vol (10 day) 3523.67k
Shares Outstanding 538.55M
Float 26.04M
% Held by Insiders 18.08%
% Held by Institutions 156.57%
Shares Short (Sep. 29, 2020) 44.49M
Short Ratio (Sep. 29, 2020) 412.87
Short % of Float (Sep. 29, 2020) 412.88%
Short % of Shares Outstanding (Sep. 29, 2020) 411.66%
Shares Short (prior month Aug. 30, 2020) 43.59M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2019
Most Recent Quarter (mrq)Jun. 29, 2020


Profit Margin 0.00%
Operating Margin (ttm)-3,893.47%

Management Effectiveness

Return on Assets (ttm)-26.37%
Return on Equity (ttm)-58.28%

Income Statement

Revenue (ttm)1.52M
Revenue Per Share (ttm)0.04
Quarterly Revenue Growth (yoy)0.00%
Gross Profit (ttm)1.52M
EBITDA -58.97M
Net Income Avi to Common (ttm)-63.03M
Diluted EPS (ttm)-1.82
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)189.72M
Total Cash Per Share (mrq)4.92
Total Debt (mrq)20.56M
Total Debt/Equity (mrq)13.93
Current Ratio (mrq)15.39
Book Value Per Share (mrq)3.83

Cash Flow Statement

Operating Cash Flow (ttm)-58.59M
Levered Free Cash Flow (ttm)-34.92M